Based on 784 businesses audited.
Medical Devices, Pharma & Biotech Reputation: Eylea (Regeneron Pharmaceuticals) (eylea.us)
The site is a clinical and informational dead zone that provides zero substance to back its pharmaceutical domain signal. It serves as a technical barricade rather than a professional resource, resulting in a high BS score due to the total opacity of its claims. Any authority implied by the domain name is immediately negated by the absence of verifiable proof and identity structures.
Medical Devices, Pharma & Biotech Reputation: Eylea (Regeneron Pharmaceuticals) (eylea.us)
The domain suggests a prominent pharmaceutical product for retinal diseases, yet the content is entirely restricted to a security bot-blocking message and maintenance meta-tag. This creates a total mismatch between the high-stakes clinical industry classification and the actual technical delivery of the site.
“The score of 34 is primarily driven by the maximum failure in Information Density and Semantic Coherence pillars due to the 'Site Maintenance' state. While the site does not use active 'fluff' marketing language, the total absence of promised substance (Signal-Substance gap) triggers high forensic penalties. The score is prevented from reaching 90+ only because there is no active deception or industry cliché match present in the bot-blocking text.”